Advancing accuracy of women’s diagnostics

There is an urgent need to improve the diagnostic accuracy of tests for many women’s diseases. Research in the past has primarily focused on male subjects with little focus on gender effects in diagnostic testing.

Celula is committed to identifying new and improved ways of more accurately delivering actionable information to female patients and their physicians in a variety of diseases using our unique Integrated Diagnostic Accuracy platform approach.   Through our own R&D efforts as well as through in-licensing technologies or collaborative partnerships with others we are actively seeking opportunities to further improve the accuracy of women’s diagnostics.  Areas of particular interest include pregnancy induced hypertension and gestational diabetes as well as other gender specific genomic diseases. Please contact us for further information and possible collaborations.